More recently, we reported that bleomycin-induced pulmonary fibrosis is reduced by a nonspecific SPHK inhibitor (SKI-II) [15] or conditional deletion of Sphk1 in murine AEC or fibroblasts, but not in endothelial cells [21]. Here, SPHK1 is linked to pulmonary fibrosis.